Capricor Therapeutics Announces Long-Term Benefit of Deramiocel (Cap-1002) in Both Skeletal Muscle and Cardiac Function in the Hope-2 Ole Study in Duchenne Muscular Dystrophy
capricor therapeutics宣佈在Duchenne肌肉萎縮症的Hope-2 Ole研究中，Deramiocel (Cap-1002)對骨骼肌和心臟功能的長期效益。